These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2784529

  • 1. Monoamine oxidase inhibitory properties of milacemide in rats.
    Truong DD, Diamond B, Pezzoli G, Mena MA, Fahn S.
    Life Sci; 1989; 44(15):1059-66. PubMed ID: 2784529
    [Abstract] [Full Text] [Related]

  • 2. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P, Cavalier R, David-Remacle M, Youdim MB.
    J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice.
    Colombo M, Strolin Benedetti M, Bonsignori A, Cocchiara G, Roncucci R, Dostert P.
    J Neural Transm Suppl; 1990 Apr; 32():123-9. PubMed ID: 2089081
    [Abstract] [Full Text] [Related]

  • 8. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.
    O'Brien EM, Dostert P, Tipton KF.
    Biochem Pharmacol; 1995 Jul 31; 50(3):317-24. PubMed ID: 7646533
    [Abstract] [Full Text] [Related]

  • 9. Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase.
    O'Brien EM, Dostert P, Pevarello P, Tipton KF.
    Biochem Pharmacol; 1994 Aug 30; 48(5):905-14. PubMed ID: 8093103
    [Abstract] [Full Text] [Related]

  • 10. Milacemide, a glycine pro-drug, inhibits strychnine-allodynia without affecting normal nociception in the rat.
    Khandwala H, Loomis CW.
    Pain; 1998 Jul 30; 77(1):87-95. PubMed ID: 9755023
    [Abstract] [Full Text] [Related]

  • 11. Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide.
    Semba J, Curzon G, Patsalos PN.
    Br J Pharmacol; 1993 Apr 30; 108(4):1117-24. PubMed ID: 8485621
    [Abstract] [Full Text] [Related]

  • 12. Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?
    Strolin Benedetti M, Cocchiara G, Colombo M, Dostert P.
    J Neural Transm Suppl; 1990 Apr 30; 32():351-6. PubMed ID: 2128509
    [Abstract] [Full Text] [Related]

  • 13. Ring-substituted analogues of tranylcypromine as monoamine oxidase inhibitors.
    Sherry RL, Baker GB, Coutts RT, Mousseau DD.
    J Neural Transm Suppl; 1990 Apr 30; 32():107-12. PubMed ID: 1982446
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of vocal and nonvocal behavior in adult squirrel monkeys by selective MAO-A and MAO-B inhibition.
    Newman JD, Winslow JT, Murphy DL.
    Brain Res; 1991 Jan 04; 538(1):24-8. PubMed ID: 1902133
    [Abstract] [Full Text] [Related]

  • 19. Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.
    Ashkenazi R, Finberg JP, Youdim MB.
    Br J Pharmacol; 1983 Jul 04; 79(3):765-70. PubMed ID: 6418248
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of monoamine oxidase B by analogues of the anticonvulsant agent milacemide (2-(n-pentylamino)acetamide).
    Nishimura K, Lu X, Silverman RB.
    J Med Chem; 1993 Feb 19; 36(4):446-8. PubMed ID: 8474100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.